GLP-1 Agonists Weight Loss Drugs Market Strengthens Partnerships

bir ses eklendi Otro

2026-02-23 06:04:14 - Translate

The global GLP-1 agonists weight loss drugs market size was estimated at USD 13.84 billion in 2024 and is projected to reach USD 48.84 billion by 2030, registering a CAGR of 18.54% from 2025 to 2030. Market expansion is being propelled by the growing global burden of obesity, heightened health consciousness, and the proven clinical efficacy of leading therapies such as semaglutide...

0 Yorumlar 0 hisse senetleri 9 Views 0 önizleme